89 related articles for article (PubMed ID: 8196938)
1. Effect of genetically determined host factors on the efficacy of vidarabine, acyclovir and 5-trifluorothymidine in herpes simplex virus type 1 infection.
Abghari SZ; Stulting RD; Zhu Z; Schinazi RF; Kaufman HE
Ophthalmic Res; 1994; 26(2):95-104. PubMed ID: 8196938
[TBL] [Abstract][Full Text] [Related]
2. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
Schinazi RF; Nahmias AJ
Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
[TBL] [Abstract][Full Text] [Related]
3. Suppression of generation and replication of acyclovir-resistant herpes simplex virus by a sensitive virus.
Okuda T; Kurokawa M; Matsuo K; Honda M; Niimura M; Shiraki K
J Med Virol; 2004 Jan; 72(1):112-20. PubMed ID: 14635018
[TBL] [Abstract][Full Text] [Related]
4. In vitro synergism of trifluorothymidine and ganciclovir against HSV-1.
Hobden JA; Kumar M; Kaufman HE; Clement C; Varnell ED; Bhattacharjee PS; Hill JM
Invest Ophthalmol Vis Sci; 2011 Feb; 52(2):830-3. PubMed ID: 20861476
[TBL] [Abstract][Full Text] [Related]
5. Synergistic antiviral activity of acyclovir and vidarabine against herpes simplex virus types 1 and 2 and varicella-zoster virus.
Suzuki M; Okuda T; Shiraki K
Antiviral Res; 2006 Nov; 72(2):157-61. PubMed ID: 16797734
[TBL] [Abstract][Full Text] [Related]
6. [Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].
Andronova VL; Jasko MV; Kukhanova MK; Skoblov YS; Deryabin PG; Galegov GA
Vopr Virusol; 2014; 59(6):32-5. PubMed ID: 25929034
[TBL] [Abstract][Full Text] [Related]
7. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
[TBL] [Abstract][Full Text] [Related]
8. Comparative activities of selected combinations of acyclovir, vidarabine, arabinosyl hypoxanthine, interferon, and polyriboinosinic acid-polyribocytidylic acid complex against herpes simplex virus type 2 in tissue culture and intravaginally inoculated mice.
Crane LR; Milne DA; Sunstrum JC; Lerner AM
Antimicrob Agents Chemother; 1984 Oct; 26(4):557-62. PubMed ID: 6083754
[TBL] [Abstract][Full Text] [Related]
9. Lactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea.
Fujihara T; Hayashi K
Arch Virol; 1995; 140(8):1469-72. PubMed ID: 7661698
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol.
Liu S; Li L; Tan L; Liang X
Virol Sin; 2019 Jun; 34(3):315-323. PubMed ID: 30915606
[TBL] [Abstract][Full Text] [Related]
11. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA.
Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC
J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239
[TBL] [Abstract][Full Text] [Related]
12. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
[TBL] [Abstract][Full Text] [Related]
13. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
14. Comparative replication of HSV-1 in BALB/c and C57BL/6 mouse embryo fibroblasts in vitro.
Abghari SZ; Stulting RD; Nigida SM; Downer DN; Nahmias AJ
Invest Ophthalmol Vis Sci; 1986 Jun; 27(6):909-14. PubMed ID: 3011703
[TBL] [Abstract][Full Text] [Related]
15. The synergistic effects of betulin with acyclovir against herpes simplex viruses.
Gong Y; Raj KM; Luscombe CA; Gadawski I; Tam T; Chu J; Gibson D; Carlson R; Sacks SL
Antiviral Res; 2004 Nov; 64(2):127-30. PubMed ID: 15498608
[TBL] [Abstract][Full Text] [Related]
16. The effect of HSV multiplication rate on antiviral drug efficacy in vitro.
Upadhyay JM; Hill JM; Jemison M; Helmy MF; Kaufman HE
Antiviral Res; 1991 Jan; 15(1):67-76. PubMed ID: 1852150
[TBL] [Abstract][Full Text] [Related]
17. [Sensitivities to other antiviral drugs and thymidine kinase activity of aciclovir-resistant herpes simplex virus type 1].
Nitta K; Shiota H; Naito T; Mimura Y
Nippon Ganka Gakkai Zasshi; 1994 Jun; 98(6):513-9. PubMed ID: 8030564
[TBL] [Abstract][Full Text] [Related]
18. Phosphoramidate derivatives of acyclovir: synthesis and antiviral activity in HIV-1 and HSV-1 models in vitro.
Zakirova NF; Shipitsyn AV; Jasko MV; Prokofjeva MM; Andronova VL; Galegov GA; Prassolov VS; Kochetkov SN
Bioorg Med Chem; 2012 Oct; 20(19):5802-9. PubMed ID: 22954898
[TBL] [Abstract][Full Text] [Related]
19. A new homodimer of aciclovir as a prodrug with increased solubility and antiviral activity.
Brandi G; Rossi L; Schiavano GF; Millo E; Magnani M
Int J Antimicrob Agents; 2009 Aug; 34(2):177-80. PubMed ID: 19394201
[TBL] [Abstract][Full Text] [Related]
20. Association between sensitivity of viral thymidine kinase-associated acyclovir-resistant herpes simplex virus type 1 and virulence.
Omura N; Fujii H; Yoshikawa T; Yamada S; Harada S; Inagaki T; Shibamura M; Takeyama H; Saijo M
Virol J; 2017 Mar; 14(1):59. PubMed ID: 28320407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
